Hiệu quả và độ an toàn của aspirin kết hợp với warfarin sau hội chứng vành cấp tính

Bugiardini R (2004) Risk stratification in acute coronary syndrome: focus on unstable angina/non-ST segment elevation myocardial infarction. Heart 90:729–731 Lowy FD, Waldhausen JA, Miller M, Sopko G, Rosenberg Y, Skarlatos SI (2004) Report of the National Heart, Lung and Blood Institute-National Institute of Allergy and Infectious Diseases working group on antimicrobial strategies and cardiothoracic surgery. Am Heart J 147:575–581 Lopes RD, Li L, Granger CB, Wang TY, Foody JM, Funk M et al (2012) Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes. Am J Med 125:897–905 Andreotti F, Testa L, Biondi-Zoccai GG, Crea F (2006) Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients. Eur Heart J 27:519–526 Rothberg MB, Celestin C, Fiore LD, Lawler E, Cook JR (2005) Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit. Ann Intern Med 143:241–250 Haq SA, Heitner JF, Sacchi TJ, Brener SJ (2010) Long-term effect of chronic oral anticoagulation with warfarin after acute myocardial infarction. Am J Med 123:250–258 Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558 Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560 DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188 Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634 Fiore LD, Ezekowitz MD, Brophy MT, Lu D, Sacco J, Peduzzi P (2002) Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study. Circulation 105:557–563 Huynh T, Theroux P, Bogaty P, Nasmith J, Solymoss S (2001) Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery. Circulation 103:3069–3074 Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H (2002) Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 347:969–974 Cohen M, Adams PC, Parry G, Xiong J, Chamberlain D, Wieczorek I et al (1994) Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Circulation 89:81–88 Coumadin Aspirin Reinfarction Study (CARS) Investigators (1997) Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Lancet 350:389–396 Anand SS, Yusuf S, Pogue J, Weitz JI, Flather M (1998) Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results. Circulation 98:1064–1070 van Es RF, Jonker JJ, Verheugt FW, Deckers JW, Grobbee DE (2002) Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet 360:109–113 Brouwer MA, van den Bergh PJ, Aengevaeren WR, Veen G, Luijten HE, Hertzberger DP et al (2002) Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial. Circulation 106:659–665 Herlitz J, Holm J, Peterson M, Karlson BW, Haglid Evander M, Erhardt L (2004) Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study. Eur Heart J 25:232–239 The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators (2001) Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. J Am Coll Cardiol 37:475–484 Williams MJ, Morison IM, Parker JH, Stewart RA (1997) Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary study. J Am Coll Cardiol 30:364–369 Cohen M, Adams PC, Hawkins L, Bach M, Fuster V (1990) Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group). Am J Cardiol 66:1287 Zibaeenezhad MJ, Mowla A, Sorbi MH (2004) Warfarin and aspirin versus aspirin alone in patients with acute myocardial infarction: a pilot study. Angiology 55:17–20 Smith P, Arnesen H, Holme I (1990) The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 323:147–152 Walenga JM, Hoppensteadt D, Pifarre R, Cressman MD, Hunninghake DB, Fox NL et al (1999) Hemostatic effects of 1 mg daily warfarin on post CABG patients. Post CABG Studies Investigators. J Thromb Thrombolysis 7:313–318 Parashar S, Kella D, Reid KJ, Spertus JA, Tang F, Langberg J et al (2013) New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry). Am J Cardiol 112:1390